| Patent Number |
Title Of Patent |
Date Issued |
| 6992095 |
Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
January 31, 2006 |
| The invention relates to novel stilbene compounds having the general formula (I): ##STR00001## as well as to pharmaceutical compositions for use in human or veterinary medicine, including dermatological, rheumatic, respiratory, cardiovascular and ophthalmic conditions and cosmetic |
| 6992094 |
Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
January 31, 2006 |
| The invention concerns novel diarylselenide compounds corresponding to the general formula (I) and the use thereof in pharmaceutical compositions in human or veterinary medicine (in the treatment of dermatological, rheumatic, cardiovascular and ophthalmologic pathologies in particular), |
| 6927228 |
Biaromatic compound activators of PPAR.gamma.-type receptors |
August 9, 2005 |
| The invention relates to novel biaromatic compounds which correspond to the general formula (I) below: ##STR1##and also to the method for preparing them and their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology, and also in the fiel |
| 6924400 |
Triaromatic vitamin D analogues |
August 2, 2005 |
| The invention relates, as novel and useful industrial products, to triaromatic compounds, which are vitamin D analogues, of general formula (I): ##STR1##and also to a method for preparing them and to their use in pharmaceutical compositions intended for use in human or veterinary med |
| 6924388 |
Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
August 2, 2005 |
| Novel pharmaceutically/cosmetically-active bicyclic aromatic compounds having the structural formula (I): ##STR1##in which Ar.sub.1 is a radical having one of the structural formulae (a)-(c): ##STR2##and Ar.sub.2, X.sub.1, R.sup.1, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.s |
| 6921777 |
Heteroethynylenic compounds and pharmaceutical and cosmetic compositions containing them |
July 26, 2005 |
| The invention relates to novel heteroethynylenic compounds having the general formula (I): ##STR1##as well as to the use of these compounds in pharmaceutical compositions intended for use in human or veterinary medicine (dermatological, rheumatic, respiratory, cardiovascular and opht |
| 6908939 |
Biaromatic ligand activators of PPAR.gamma. receptors |
June 21, 2005 |
| Novel pharmaceutical/cosmetic compositions contain at least one biaromatic ligand activator of a PPAR.gamma. receptor, such biaromatic ligand having the structural formula (I): ##STR1##and are well suited, inter alia, for regulating and/or restoring skin lipid metabolism, for treatin |
| 6878842 |
Process for the enantioselective synthesis of propargyl alcohol derivatives of R configuration f |
April 12, 2005 |
| The invention relates to a novel process for synthesizing organic compounds of general formula (I): ##STR1## said process may be carried out on an industrial scale and makes it possible to obtain from a mixture of racemic alcohols of formula (II), ##STR2##the corresponding chiral |
| 6858647 |
Retinoid compounds suited for antibacterial applications |
February 22, 2005 |
| A variety of retinoid compounds well suited for preventively or curatively treating a bacterial colonization infesting/infecting an individual subject exhibit pronounced antibacterial activity, notably pronounced antibacterial activity in respect of the bacterium Staphylococcus aureus, |
| 6831106 |
Vitamin D analogues |
December 14, 2004 |
| The present invention relates to novel triaromatic compounds having the general formula (I): ##STR1##as well as to a method for preparing them and to their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology, in carcinology and in the f |
| 6825360 |
Bicyclic aromatic compounds |
November 30, 2004 |
| The invention relates to novel bicyclic aromatic compounds which have the general formula (I): ##STR1##as well as to the use of these compounds in pharmaceutical compositions intended for use in human or veterinary medicine (dermatological, rheumatic, respiratory, cardiovascular and |
| 6825226 |
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for c |
November 30, 2004 |
| The invention relates to the discovery that specific adamantyl or adamantyl group derivatives containing retinoid-related compounds induce apoptosis of cancer cells and therefore may be used for the treatment of cancer, including advanced cancer. Also, the present invention relates to no |
| 6803382 |
Angiogenesis inhibitors and pharmaceutical and cosmetic use thereof |
October 12, 2004 |
| The invention relates to novel 1-oxaspiro[2,5]octan-6-ol derivatives of general formula (I): ##STR1##and also to a method for preparing them, and to their use in pharmaceutical compositions for use in human or veterinary medicine, or in cosmetic compositions. |
| 6706725 |
Vitamin D analogues |
March 16, 2004 |
| The invention relates to novel bicyclic compounds having the general formula (I): ##STR1##as well as to a method for preparing them and to their use in pharmaceutical compositions intended for use in human or veterinary medicine (in dermatology, in carcinology and in the field of aut |
| 6689922 |
Vitamin D analogues |
February 10, 2004 |
| The invention concerns novel bi-aromatic compounds having the formula: ##STR1##which are analogs of vitamin D, the process of preparing them, as well as their use in pharmaceutical compositions in human or veterinary medicine, particularly in dermatology, cancer treatment, treatment of a |
| 6686386 |
Use of a RAR-.gamma.-specific agonist ligand for increasing the rate of apoptosis |
February 3, 2004 |
| The present invention relates to pharmaceutical and cosmetic compositions comprising at least one agonist ligand, which is specific for receptors of the RAR-.gamma. type, which are characterized as inducers of apoptosis in at least one cell population in which apoptosis can be induced by |
| 6632963 |
Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
October 14, 2003 |
| Novel pharmaceutically/cosmetically-active bicyclic aromatic compounds have the structural formula (I): ##STR1##in which Ar.sub.1 is a radical having one of the structural formulae (a)-(c): ##STR2##Ar.sub.2 is a radical having one of the following formulae (d)-(h): ##STR3##and X |
| 6562025 |
Apparatus for uniting the lips of a wound, a holding piece, and a cosmetic treatment method |
May 13, 2003 |
| The apparatus for uniting the lips of a wound comprises a laser having an emission wavelength chosen such that it can perform tissue bonding and unite the lips of a wound, and a holding piece suitable for being secured to the tissue around the wound so as to keep the lips of the wound |
| 6462064 |
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for c |
October 8, 2002 |
| The invention relates to the discovery that specific adamantyl or adamantyl group derivatives containing retinoid-related compounds induce apoptosis of cancer cells and therefore may be used for the treatment of cancer, including advanced cancer. Also, the present invention relates to no |
| 6444709 |
Heteroethylene compounds and pharmaceutical and cosmetic compositions containing same |
September 3, 2002 |
| The invention relates to novel heteroethynylenic compounds having the general formula (I): ##STR1##as well as to the use of these compounds in pharmaceutical compositions intended for use in human or veterinary medicine (dermatological, rheumatic, respiratory, cardiovascular and opht |
| 6403656 |
Use of ppar-.gamma. activators in dermatology |
June 11, 2002 |
| The invention concerns the use of at least one activator of receptors of the PPAR-.gamma. type for preparing a pharmaceutical composition for treating skin disorders related to an anomaly of the differentiation of epidermic cells. |
| 6214878 |
Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
April 10, 2001 |
| The invention relates to novel stilbene compounds having the general formula (I): ##STR1##as well as to pharmaceutical compositions for use in human or veterinary medicine, including dermatological, rheumatic, respiratory, cardiovascular and ophthalmic conditions and cosmetic composi |
| 6127415 |
Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
October 3, 2000 |
| The present invention relates to specific adamantyl or adamantyl group derivative containing retinoid compounds induce apoptosis of cancer cells. These adamantyl retinoid derivatives are useful for the treatment of many cancers and solid tumors, especially androgen-independent prostate c |
| 6043280 |
Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central ner |
March 28, 2000 |
| This invention relates to the use of benzonaphthalene compounds for the treatment of peripheral neuropathies, central neurodegenerative diseases and autoimmune diseases of the nervous system. |
| 6028114 |
Use of aminothiolester derivatives in pharmaceutics |
February 22, 2000 |
| Use of at least one aminothiol ester derivative for the preparation of a pharmaceutical composition intended to increase the inhibition of a character resistant to the induction of apoptosis of transformed cells, this character being due to the bc12 gene present in these cells. The p |
